89R5234 SCL-F     By: Slawson H.B. No. 1088       A BILL TO BE ENTITLED   AN ACT   relating to the statute of limitations on a health care liability   claim involving certain gender modification drugs provided to and   procedures performed on a minor.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  Section 74.251, Civil Practice and Remedies   Code, is amended to read as follows:          Sec. 74.251.  GENERAL STATUTE OF LIMITATIONS AND REPOSE ON   HEALTH CARE LIABILITY CLAIMS. (a) Notwithstanding any other law,   except as provided by Section 74.252, and subject to Subsection   (b), no health care liability claim may be commenced unless the   action is filed within two years from the occurrence of the breach   or tort or from the date the medical or health care treatment that   is the subject of the claim or the hospitalization for which the   claim is made is completed; provided that, minors under the age of   12 years shall have until their 14th birthday in which to file, or   have filed on their behalf, the claim. Except as herein provided   this section applies to all persons regardless of minority or other   legal disability.          (b)  Except for a health care liability claim described by   Section 74.252, a [A] claimant must bring a health care liability   claim not later than 10 years after the date of the act or omission   that gives rise to the claim.  This subsection is intended as a   statute of repose so that all claims must be brought within 10 years   or they are time barred.          SECTION 2.  Subchapter F, Chapter 74, Civil Practice and   Remedies Code, is amended by adding Section 74.252 to read as   follows:          Sec. 74.252.  STATUTE OF LIMITATIONS ON HEALTH CARE   LIABILITY CLAIMS INVOLVING CERTAIN GENDER MODIFICATION DRUGS AND   PROCEDURES. A claimant must bring a health care liability claim not   later than the claimant's 25th birthday if:                (1)  the claimant is a minor at the time the cause of   action accrues; and                (2)  the basis for the claim is malpractice in the   provision of a puberty suppression prescription drug or cross-sex   hormone to or the performance of surgery or another medical   procedure on the minor for the purpose of gender transitioning or   gender reassignment.          SECTION 3.  The changes in law made by this Act apply only to   a cause of action that accrues on or after the effective date of   this Act.          SECTION 4.  This Act takes effect September 1, 2025.